Skip to content
Search

Latest Stories

RPS England welcomes appointment of Amanda Pritchard as NHS chief

The Royal Pharmaceutical Society (RPS) welcomed the news that Amanda Pritchard has been appointed as the first female chief executive of NHS England.

Pritchard, who is currently NHS England's chief operating officer, will assume the new role on August 1.


Thorrun Govind, Chair of RPS England, said: “This appointment comes at a crucial time for the health service in England; recovering from the pandemic, with teams under continued pressure, growing demand on services, and forthcoming NHS reforms.

“Pharmacists and pharmacy teams have given their all during Covid-19 and amid all these changes it’s vital staff get the support they need.

“A key challenge for the NHS will be implementing new Integrated Care Systems and this must include a focus on medicines optimisation across care settings.

“I’d urge NHS England to ensure a voice for pharmacy to help make these changes a success."

RPS hopes the new chief executive will work effectively with professional leadership bodies, who will offer expert advice and insights to help support much-needed reforms to NHS England.

“Delivering integrated health and care services throughout England will also depend on investment in our workforce and a long-overdue upgrade to health and care records,” Thorrun added.

“I look forward to working with Amanda and the NHS leadership on how pharmacists’ clinical expertise can support the NHS recovery, improve medicines safety, and deliver high-quality patient care for the future.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less